nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—ABCB1—ulcerative colitis	0.255	1	CbGaD
Lapatinib—CYP2C8—Nicotine—ulcerative colitis	0.0346	0.0739	CbGbCtD
Lapatinib—CYP3A4—Budesonide—ulcerative colitis	0.0322	0.0688	CbGbCtD
Lapatinib—CYP2C8—Cholecalciferol—ulcerative colitis	0.031	0.0662	CbGbCtD
Lapatinib—CYP2C19—Nicotine—ulcerative colitis	0.029	0.062	CbGbCtD
Lapatinib—CYP3A5—Sulfasalazine—ulcerative colitis	0.028	0.0597	CbGbCtD
Lapatinib—CYP2C19—Cholecalciferol—ulcerative colitis	0.026	0.0556	CbGbCtD
Lapatinib—ABCB1—Methylprednisolone—ulcerative colitis	0.024	0.0513	CbGbCtD
Lapatinib—CYP3A5—Hydrocortisone—ulcerative colitis	0.0224	0.0479	CbGbCtD
Lapatinib—CYP2C8—Hydrocortisone—ulcerative colitis	0.0216	0.0461	CbGbCtD
Lapatinib—CYP2C19—Prednisone—ulcerative colitis	0.018	0.0385	CbGbCtD
Lapatinib—ABCB1—Betamethasone—ulcerative colitis	0.0156	0.0334	CbGbCtD
Lapatinib—ABCB1—Prednisolone—ulcerative colitis	0.0154	0.0329	CbGbCtD
Lapatinib—ABCB1—Hydrocortisone—ulcerative colitis	0.0146	0.0312	CbGbCtD
Lapatinib—ABCB1—Prednisone—ulcerative colitis	0.0146	0.0311	CbGbCtD
Lapatinib—CYP3A4—Methylprednisolone—ulcerative colitis	0.0144	0.0307	CbGbCtD
Lapatinib—CYP3A4—Nicotine—ulcerative colitis	0.014	0.03	CbGbCtD
Lapatinib—CYP3A5—Dexamethasone—ulcerative colitis	0.014	0.0298	CbGbCtD
Lapatinib—CYP2C8—Dexamethasone—ulcerative colitis	0.0134	0.0287	CbGbCtD
Lapatinib—CYP3A4—Cholecalciferol—ulcerative colitis	0.0126	0.0269	CbGbCtD
Lapatinib—CYP2C19—Dexamethasone—ulcerative colitis	0.0113	0.024	CbGbCtD
Lapatinib—CYP3A4—Triamcinolone—ulcerative colitis	0.0109	0.0233	CbGbCtD
Lapatinib—CYP3A4—Betamethasone—ulcerative colitis	0.00936	0.02	CbGbCtD
Lapatinib—CYP3A4—Prednisolone—ulcerative colitis	0.00923	0.0197	CbGbCtD
Lapatinib—ABCB1—Dexamethasone—ulcerative colitis	0.00908	0.0194	CbGbCtD
Lapatinib—CYP3A4—Hydrocortisone—ulcerative colitis	0.00875	0.0187	CbGbCtD
Lapatinib—CYP3A4—Prednisone—ulcerative colitis	0.00872	0.0186	CbGbCtD
Lapatinib—CYP3A4—Dexamethasone—ulcerative colitis	0.00544	0.0116	CbGbCtD
Lapatinib—ERBB2—epithelium—ulcerative colitis	0.00236	0.0998	CbGeAlD
Lapatinib—ERBB4—epithelium—ulcerative colitis	0.00236	0.0998	CbGeAlD
Lapatinib—ERBB2—smooth muscle tissue—ulcerative colitis	0.00227	0.0961	CbGeAlD
Lapatinib—PI4KB—smooth muscle tissue—ulcerative colitis	0.00213	0.09	CbGeAlD
Lapatinib—TAP1—liver—ulcerative colitis	0.00183	0.0774	CbGeAlD
Lapatinib—ERBB2—lymphoid tissue—ulcerative colitis	0.00182	0.0768	CbGeAlD
Lapatinib—ERBB2—digestive system—ulcerative colitis	0.00179	0.0759	CbGeAlD
Lapatinib—PIK3C2B—liver—ulcerative colitis	0.00172	0.0727	CbGeAlD
Lapatinib—ERBB2—liver—ulcerative colitis	0.00134	0.0565	CbGeAlD
Lapatinib—PI4KB—liver—ulcerative colitis	0.00125	0.053	CbGeAlD
Lapatinib—EGFR—liver—ulcerative colitis	0.00113	0.0479	CbGeAlD
Lapatinib—CYP2C19—digestive system—ulcerative colitis	0.000559	0.0236	CbGeAlD
Lapatinib—CYP3A5—digestive system—ulcerative colitis	0.00044	0.0186	CbGeAlD
Lapatinib—CYP2C19—liver—ulcerative colitis	0.000416	0.0176	CbGeAlD
Lapatinib—Gefitinib—ALB—ulcerative colitis	0.000415	0.512	CrCbGaD
Lapatinib—Gefitinib—ABCB1—ulcerative colitis	0.000396	0.488	CrCbGaD
Lapatinib—PIK3C2B—Exemestane—Methylprednisolone—ulcerative colitis	0.000385	0.0676	CbGdCrCtD
Lapatinib—CYP2C8—liver—ulcerative colitis	0.000363	0.0154	CbGeAlD
Lapatinib—ERBB2—Triamcinolone—Budesonide—ulcerative colitis	0.000357	0.0628	CbGdCrCtD
Lapatinib—PIK3C2B—Exemestane—Prednisone—ulcerative colitis	0.000351	0.0617	CbGdCrCtD
Lapatinib—PIK3C2B—Exemestane—Prednisolone—ulcerative colitis	0.000343	0.0602	CbGdCrCtD
Lapatinib—ERBB2—Desoximetasone—Budesonide—ulcerative colitis	0.000339	0.0596	CbGdCrCtD
Lapatinib—CYP3A4—digestive system—ulcerative colitis	0.00033	0.014	CbGeAlD
Lapatinib—CYP3A5—liver—ulcerative colitis	0.000328	0.0139	CbGeAlD
Lapatinib—Myalgia—Azathioprine—ulcerative colitis	0.000321	0.00272	CcSEcCtD
Lapatinib—Arthralgia—Azathioprine—ulcerative colitis	0.000321	0.00272	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—ulcerative colitis	0.000319	0.0027	CcSEcCtD
Lapatinib—Vomiting—Nicotine—ulcerative colitis	0.000318	0.0027	CcSEcCtD
Lapatinib—Dry skin—Dexamethasone—ulcerative colitis	0.000317	0.00269	CcSEcCtD
Lapatinib—Dry skin—Betamethasone—ulcerative colitis	0.000317	0.00269	CcSEcCtD
Lapatinib—Anaemia—Mesalazine—ulcerative colitis	0.000317	0.00269	CcSEcCtD
Lapatinib—ERBB2—Exemestane—Methylprednisolone—ulcerative colitis	0.000317	0.0557	CbGdCrCtD
Lapatinib—Rash—Nicotine—ulcerative colitis	0.000315	0.00268	CcSEcCtD
Lapatinib—Dermatitis—Nicotine—ulcerative colitis	0.000315	0.00267	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.000314	0.00266	CcSEcCtD
Lapatinib—Neuropathy peripheral—Prednisolone—ulcerative colitis	0.000313	0.00266	CcSEcCtD
Lapatinib—Headache—Nicotine—ulcerative colitis	0.000313	0.00266	CcSEcCtD
Lapatinib—Infestation NOS—Hydrocortisone—ulcerative colitis	0.000312	0.00265	CcSEcCtD
Lapatinib—Infestation—Hydrocortisone—ulcerative colitis	0.000312	0.00265	CcSEcCtD
Lapatinib—Insomnia—Budesonide—ulcerative colitis	0.000311	0.00264	CcSEcCtD
Lapatinib—Cardiac failure—Prednisone—ulcerative colitis	0.000309	0.00262	CcSEcCtD
Lapatinib—ABCB1—epithelium—ulcerative colitis	0.000307	0.013	CbGeAlD
Lapatinib—Leukopenia—Mesalazine—ulcerative colitis	0.000307	0.00261	CcSEcCtD
Lapatinib—Dyspnoea—Budesonide—ulcerative colitis	0.000307	0.00261	CcSEcCtD
Lapatinib—Nausea—Mercaptopurine—ulcerative colitis	0.000307	0.0026	CcSEcCtD
Lapatinib—Neuropathy peripheral—Hydrocortisone—ulcerative colitis	0.000306	0.0026	CcSEcCtD
Lapatinib—Infection—Azathioprine—ulcerative colitis	0.000305	0.00259	CcSEcCtD
Lapatinib—Palpitations—Mesalazine—ulcerative colitis	0.000303	0.00258	CcSEcCtD
Lapatinib—Dyspepsia—Budesonide—ulcerative colitis	0.000303	0.00257	CcSEcCtD
Lapatinib—Cough—Mesalazine—ulcerative colitis	0.000299	0.00254	CcSEcCtD
Lapatinib—Decreased appetite—Budesonide—ulcerative colitis	0.000299	0.00254	CcSEcCtD
Lapatinib—Skin disorder—Azathioprine—ulcerative colitis	0.000299	0.00254	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000297	0.00252	CcSEcCtD
Lapatinib—Nausea—Nicotine—ulcerative colitis	0.000297	0.00252	CcSEcCtD
Lapatinib—Fatigue—Budesonide—ulcerative colitis	0.000297	0.00252	CcSEcCtD
Lapatinib—Constipation—Budesonide—ulcerative colitis	0.000295	0.0025	CcSEcCtD
Lapatinib—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000293	0.00249	CcSEcCtD
Lapatinib—Infestation—Methylprednisolone—ulcerative colitis	0.000293	0.00249	CcSEcCtD
Lapatinib—Arthralgia—Mesalazine—ulcerative colitis	0.000292	0.00248	CcSEcCtD
Lapatinib—Myalgia—Mesalazine—ulcerative colitis	0.000292	0.00248	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.00029	0.00246	CcSEcCtD
Lapatinib—ERBB2—Exemestane—Prednisone—ulcerative colitis	0.000289	0.0508	CbGdCrCtD
Lapatinib—Neuropathy peripheral—Triamcinolone—ulcerative colitis	0.000288	0.00245	CcSEcCtD
Lapatinib—Neuropathy peripheral—Methylprednisolone—ulcerative colitis	0.000288	0.00244	CcSEcCtD
Lapatinib—ERBB2—Exemestane—Prednisolone—ulcerative colitis	0.000282	0.0496	CbGdCrCtD
Lapatinib—Gastrointestinal pain—Budesonide—ulcerative colitis	0.000282	0.00239	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.00028	0.00238	CcSEcCtD
Lapatinib—Anaphylactic shock—Mesalazine—ulcerative colitis	0.00028	0.00238	CcSEcCtD
Lapatinib—Infection—Mesalazine—ulcerative colitis	0.000278	0.00236	CcSEcCtD
Lapatinib—Epistaxis—Triamcinolone—ulcerative colitis	0.000277	0.00236	CcSEcCtD
Lapatinib—Dry skin—Prednisone—ulcerative colitis	0.000276	0.00235	CcSEcCtD
Lapatinib—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000275	0.00234	CcSEcCtD
Lapatinib—Nervous system disorder—Mesalazine—ulcerative colitis	0.000275	0.00233	CcSEcCtD
Lapatinib—Abdominal pain—Budesonide—ulcerative colitis	0.000272	0.00231	CcSEcCtD
Lapatinib—Skin disorder—Mesalazine—ulcerative colitis	0.000272	0.00231	CcSEcCtD
Lapatinib—Anorexia—Mesalazine—ulcerative colitis	0.000267	0.00227	CcSEcCtD
Lapatinib—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000266	0.00226	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000265	0.00225	CcSEcCtD
Lapatinib—Neuropathy peripheral—Dexamethasone—ulcerative colitis	0.000262	0.00222	CcSEcCtD
Lapatinib—Neuropathy peripheral—Betamethasone—ulcerative colitis	0.000262	0.00222	CcSEcCtD
Lapatinib—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000259	0.0022	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000255	0.00217	CcSEcCtD
Lapatinib—Hypersensitivity—Budesonide—ulcerative colitis	0.000254	0.00215	CcSEcCtD
Lapatinib—Insomnia—Mesalazine—ulcerative colitis	0.000253	0.00215	CcSEcCtD
Lapatinib—Immune system disorder—Hydrocortisone—ulcerative colitis	0.000253	0.00215	CcSEcCtD
Lapatinib—Gastrointestinal pain—Azathioprine—ulcerative colitis	0.000251	0.00214	CcSEcCtD
Lapatinib—Dyspnoea—Mesalazine—ulcerative colitis	0.00025	0.00212	CcSEcCtD
Lapatinib—Asthenia—Budesonide—ulcerative colitis	0.000247	0.0021	CcSEcCtD
Lapatinib—Dyspepsia—Mesalazine—ulcerative colitis	0.000247	0.00209	CcSEcCtD
Lapatinib—CYP3A4—liver—ulcerative colitis	0.000246	0.0104	CbGeAlD
Lapatinib—Mental disorder—Hydrocortisone—ulcerative colitis	0.000246	0.00209	CcSEcCtD
Lapatinib—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000244	0.00208	CcSEcCtD
Lapatinib—Malnutrition—Hydrocortisone—ulcerative colitis	0.000244	0.00207	CcSEcCtD
Lapatinib—Neutropenia—Prednisone—ulcerative colitis	0.000244	0.00207	CcSEcCtD
Lapatinib—Pruritus—Budesonide—ulcerative colitis	0.000244	0.00207	CcSEcCtD
Lapatinib—Decreased appetite—Mesalazine—ulcerative colitis	0.000243	0.00207	CcSEcCtD
Lapatinib—Abdominal pain—Azathioprine—ulcerative colitis	0.000243	0.00206	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000242	0.00205	CcSEcCtD
Lapatinib—Fatigue—Mesalazine—ulcerative colitis	0.000241	0.00205	CcSEcCtD
Lapatinib—Constipation—Mesalazine—ulcerative colitis	0.00024	0.00203	CcSEcCtD
Lapatinib—Angiopathy—Methylprednisolone—ulcerative colitis	0.000239	0.00203	CcSEcCtD
Lapatinib—Immune system disorder—Methylprednisolone—ulcerative colitis	0.000238	0.00202	CcSEcCtD
Lapatinib—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000237	0.00202	CcSEcCtD
Lapatinib—ABCB1—lymphoid tissue—ulcerative colitis	0.000237	0.01	CbGeAlD
Lapatinib—Diarrhoea—Budesonide—ulcerative colitis	0.000236	0.002	CcSEcCtD
Lapatinib—ABCB1—digestive system—ulcerative colitis	0.000234	0.00989	CbGeAlD
Lapatinib—Mental disorder—Methylprednisolone—ulcerative colitis	0.000231	0.00196	CcSEcCtD
Lapatinib—Malnutrition—Methylprednisolone—ulcerative colitis	0.000229	0.00195	CcSEcCtD
Lapatinib—Gastrointestinal pain—Mesalazine—ulcerative colitis	0.000229	0.00194	CcSEcCtD
Lapatinib—Neuropathy peripheral—Prednisone—ulcerative colitis	0.000228	0.00193	CcSEcCtD
Lapatinib—Hypersensitivity—Azathioprine—ulcerative colitis	0.000227	0.00192	CcSEcCtD
Lapatinib—Back pain—Triamcinolone—ulcerative colitis	0.000222	0.00189	CcSEcCtD
Lapatinib—Abdominal pain—Mesalazine—ulcerative colitis	0.000221	0.00188	CcSEcCtD
Lapatinib—Vomiting—Budesonide—ulcerative colitis	0.000219	0.00186	CcSEcCtD
Lapatinib—Angiopathy—Betamethasone—ulcerative colitis	0.000217	0.00185	CcSEcCtD
Lapatinib—Angiopathy—Dexamethasone—ulcerative colitis	0.000217	0.00185	CcSEcCtD
Lapatinib—Rash—Budesonide—ulcerative colitis	0.000217	0.00184	CcSEcCtD
Lapatinib—Dermatitis—Budesonide—ulcerative colitis	0.000217	0.00184	CcSEcCtD
Lapatinib—Headache—Budesonide—ulcerative colitis	0.000216	0.00183	CcSEcCtD
Lapatinib—Alopecia—Betamethasone—ulcerative colitis	0.000212	0.0018	CcSEcCtD
Lapatinib—Alopecia—Dexamethasone—ulcerative colitis	0.000212	0.0018	CcSEcCtD
Lapatinib—Diarrhoea—Azathioprine—ulcerative colitis	0.00021	0.00179	CcSEcCtD
Lapatinib—Myalgia—Hydrocortisone—ulcerative colitis	0.000208	0.00176	CcSEcCtD
Lapatinib—PIK3C2B—Testosterone Propionate—Hydrocortisone—ulcerative colitis	0.000207	0.0364	CbGdCrCtD
Lapatinib—Hypersensitivity—Mesalazine—ulcerative colitis	0.000206	0.00175	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	0.000206	0.00175	CcSEcCtD
Lapatinib—Connective tissue disorder—Prednisone—ulcerative colitis	0.000205	0.00174	CcSEcCtD
Lapatinib—Nausea—Budesonide—ulcerative colitis	0.000205	0.00174	CcSEcCtD
Lapatinib—Anaphylactic shock—Prednisolone—ulcerative colitis	0.000204	0.00173	CcSEcCtD
Lapatinib—Asthenia—Mesalazine—ulcerative colitis	0.000201	0.00171	CcSEcCtD
Lapatinib—Cough—Triamcinolone—ulcerative colitis	0.000201	0.0017	CcSEcCtD
Lapatinib—Anaphylactic shock—Hydrocortisone—ulcerative colitis	0.000199	0.00169	CcSEcCtD
Lapatinib—Pruritus—Mesalazine—ulcerative colitis	0.000198	0.00168	CcSEcCtD
Lapatinib—Infection—Hydrocortisone—ulcerative colitis	0.000198	0.00168	CcSEcCtD
Lapatinib—Myalgia—Triamcinolone—ulcerative colitis	0.000196	0.00166	CcSEcCtD
Lapatinib—Vomiting—Azathioprine—ulcerative colitis	0.000196	0.00166	CcSEcCtD
Lapatinib—Nervous system disorder—Hydrocortisone—ulcerative colitis	0.000195	0.00166	CcSEcCtD
Lapatinib—Arthralgia—Methylprednisolone—ulcerative colitis	0.000195	0.00166	CcSEcCtD
Lapatinib—Myalgia—Methylprednisolone—ulcerative colitis	0.000195	0.00166	CcSEcCtD
Lapatinib—Rash—Azathioprine—ulcerative colitis	0.000194	0.00165	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	0.000194	0.00165	CcSEcCtD
Lapatinib—Dermatitis—Azathioprine—ulcerative colitis	0.000194	0.00164	CcSEcCtD
Lapatinib—Skin disorder—Hydrocortisone—ulcerative colitis	0.000193	0.00164	CcSEcCtD
Lapatinib—Headache—Azathioprine—ulcerative colitis	0.000193	0.00164	CcSEcCtD
Lapatinib—Diarrhoea—Mesalazine—ulcerative colitis	0.000192	0.00163	CcSEcCtD
Lapatinib—Anorexia—Hydrocortisone—ulcerative colitis	0.00019	0.00161	CcSEcCtD
Lapatinib—Angiopathy—Prednisone—ulcerative colitis	0.000189	0.00161	CcSEcCtD
Lapatinib—Immune system disorder—Prednisone—ulcerative colitis	0.000188	0.0016	CcSEcCtD
Lapatinib—Anaphylactic shock—Triamcinolone—ulcerative colitis	0.000188	0.00159	CcSEcCtD
Lapatinib—Anaphylactic shock—Methylprednisolone—ulcerative colitis	0.000187	0.00159	CcSEcCtD
Lapatinib—Infection—Triamcinolone—ulcerative colitis	0.000186	0.00158	CcSEcCtD
Lapatinib—Infection—Methylprednisolone—ulcerative colitis	0.000186	0.00158	CcSEcCtD
Lapatinib—Insomnia—Prednisolone—ulcerative colitis	0.000184	0.00157	CcSEcCtD
Lapatinib—Alopecia—Prednisone—ulcerative colitis	0.000184	0.00157	CcSEcCtD
Lapatinib—Nervous system disorder—Methylprednisolone—ulcerative colitis	0.000184	0.00156	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Hydrocortisone—ulcerative colitis	0.000183	0.0321	CbGdCrCtD
Lapatinib—Mental disorder—Prednisone—ulcerative colitis	0.000183	0.00155	CcSEcCtD
Lapatinib—Nausea—Azathioprine—ulcerative colitis	0.000183	0.00155	CcSEcCtD
Lapatinib—Skin disorder—Methylprednisolone—ulcerative colitis	0.000182	0.00154	CcSEcCtD
Lapatinib—Malnutrition—Prednisone—ulcerative colitis	0.000182	0.00154	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000181	0.00154	CcSEcCtD
Lapatinib—Insomnia—Hydrocortisone—ulcerative colitis	0.00018	0.00153	CcSEcCtD
Lapatinib—Vomiting—Mesalazine—ulcerative colitis	0.000178	0.00151	CcSEcCtD
Lapatinib—Myalgia—Betamethasone—ulcerative colitis	0.000178	0.00151	CcSEcCtD
Lapatinib—Myalgia—Dexamethasone—ulcerative colitis	0.000178	0.00151	CcSEcCtD
Lapatinib—Rash—Mesalazine—ulcerative colitis	0.000177	0.0015	CcSEcCtD
Lapatinib—Dermatitis—Mesalazine—ulcerative colitis	0.000176	0.0015	CcSEcCtD
Lapatinib—Headache—Mesalazine—ulcerative colitis	0.000175	0.00149	CcSEcCtD
Lapatinib—Dyspepsia—Hydrocortisone—ulcerative colitis	0.000175	0.00149	CcSEcCtD
Lapatinib—ABCB1—liver—ulcerative colitis	0.000174	0.00737	CbGeAlD
Lapatinib—ERBB2—Desoximetasone—Hydrocortisone—ulcerative colitis	0.000174	0.0305	CbGdCrCtD
Lapatinib—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000173	0.00147	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Methylprednisolone—ulcerative colitis	0.000173	0.0303	CbGdCrCtD
Lapatinib—PIK3C2B—Danazol—Hydrocortisone—ulcerative colitis	0.000172	0.0302	CbGdCrCtD
Lapatinib—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	0.000172	0.00146	CcSEcCtD
Lapatinib—Fatigue—Hydrocortisone—ulcerative colitis	0.000172	0.00146	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.000171	0.00145	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.00017	0.00145	CcSEcCtD
Lapatinib—Anaphylactic shock—Dexamethasone—ulcerative colitis	0.00017	0.00144	CcSEcCtD
Lapatinib—Anaphylactic shock—Betamethasone—ulcerative colitis	0.00017	0.00144	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Betamethasone—ulcerative colitis	0.00017	0.0299	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Dexamethasone—ulcerative colitis	0.00017	0.0299	CbGdCrCtD
Lapatinib—Insomnia—Triamcinolone—ulcerative colitis	0.00017	0.00144	CcSEcCtD
Lapatinib—Insomnia—Methylprednisolone—ulcerative colitis	0.000169	0.00144	CcSEcCtD
Lapatinib—Infection—Betamethasone—ulcerative colitis	0.000169	0.00144	CcSEcCtD
Lapatinib—Infection—Dexamethasone—ulcerative colitis	0.000169	0.00144	CcSEcCtD
Lapatinib—Anaemia—Prednisone—ulcerative colitis	0.000168	0.00143	CcSEcCtD
Lapatinib—Dyspnoea—Triamcinolone—ulcerative colitis	0.000167	0.00142	CcSEcCtD
Lapatinib—Nervous system disorder—Dexamethasone—ulcerative colitis	0.000167	0.00142	CcSEcCtD
Lapatinib—Nervous system disorder—Betamethasone—ulcerative colitis	0.000167	0.00142	CcSEcCtD
Lapatinib—Nausea—Mesalazine—ulcerative colitis	0.000166	0.00141	CcSEcCtD
Lapatinib—Dyspepsia—Triamcinolone—ulcerative colitis	0.000165	0.0014	CcSEcCtD
Lapatinib—Dyspepsia—Methylprednisolone—ulcerative colitis	0.000165	0.0014	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Methylprednisolone—ulcerative colitis	0.000164	0.0288	CbGdCrCtD
Lapatinib—Gastrointestinal pain—Hydrocortisone—ulcerative colitis	0.000163	0.00138	CcSEcCtD
Lapatinib—Anorexia—Betamethasone—ulcerative colitis	0.000162	0.00138	CcSEcCtD
Lapatinib—Anorexia—Dexamethasone—ulcerative colitis	0.000162	0.00138	CcSEcCtD
Lapatinib—Fatigue—Triamcinolone—ulcerative colitis	0.000162	0.00137	CcSEcCtD
Lapatinib—Fatigue—Methylprednisolone—ulcerative colitis	0.000161	0.00137	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Betamethasone—ulcerative colitis	0.000161	0.0283	CbGdCrCtD
Lapatinib—ERBB2—Desoximetasone—Dexamethasone—ulcerative colitis	0.000161	0.0283	CbGdCrCtD
Lapatinib—ERBB2—Desoximetasone—Triamcinolone—ulcerative colitis	0.000158	0.0277	CbGdCrCtD
Lapatinib—ERBB2—Triamcinolone—Prednisone—ulcerative colitis	0.000157	0.0277	CbGdCrCtD
Lapatinib—Abdominal pain—Hydrocortisone—ulcerative colitis	0.000157	0.00134	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000155	0.00132	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000155	0.00132	CcSEcCtD
Lapatinib—PIK3C2B—Norethindrone—Hydrocortisone—ulcerative colitis	0.000155	0.0272	CbGdCrCtD
Lapatinib—Myalgia—Prednisone—ulcerative colitis	0.000155	0.00131	CcSEcCtD
Lapatinib—Arthralgia—Prednisone—ulcerative colitis	0.000155	0.00131	CcSEcCtD
Lapatinib—Insomnia—Betamethasone—ulcerative colitis	0.000154	0.00131	CcSEcCtD
Lapatinib—Insomnia—Dexamethasone—ulcerative colitis	0.000154	0.00131	CcSEcCtD
Lapatinib—ERBB2—Triamcinolone—Prednisolone—ulcerative colitis	0.000154	0.027	CbGdCrCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	0.000154	0.0013	CcSEcCtD
Lapatinib—Gastrointestinal pain—Methylprednisolone—ulcerative colitis	0.000153	0.0013	CcSEcCtD
Lapatinib—Hypersensitivity—Prednisolone—ulcerative colitis	0.00015	0.00128	CcSEcCtD
Lapatinib—Dyspepsia—Dexamethasone—ulcerative colitis	0.00015	0.00127	CcSEcCtD
Lapatinib—Dyspepsia—Betamethasone—ulcerative colitis	0.00015	0.00127	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Prednisone—ulcerative colitis	0.00015	0.0263	CbGdCrCtD
Lapatinib—Anaphylactic shock—Prednisone—ulcerative colitis	0.000148	0.00126	CcSEcCtD
Lapatinib—PIK3C2B—Danazol—Prednisone—ulcerative colitis	0.000148	0.026	CbGdCrCtD
Lapatinib—Abdominal pain—Methylprednisolone—ulcerative colitis	0.000148	0.00126	CcSEcCtD
Lapatinib—Decreased appetite—Betamethasone—ulcerative colitis	0.000148	0.00126	CcSEcCtD
Lapatinib—Decreased appetite—Dexamethasone—ulcerative colitis	0.000148	0.00126	CcSEcCtD
Lapatinib—Infection—Prednisone—ulcerative colitis	0.000147	0.00125	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Betamethasone—ulcerative colitis	0.000147	0.00125	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	0.000147	0.00125	CcSEcCtD
Lapatinib—Hypersensitivity—Hydrocortisone—ulcerative colitis	0.000147	0.00125	CcSEcCtD
Lapatinib—Fatigue—Dexamethasone—ulcerative colitis	0.000147	0.00125	CcSEcCtD
Lapatinib—Fatigue—Betamethasone—ulcerative colitis	0.000147	0.00125	CcSEcCtD
Lapatinib—ERBB2—Desoximetasone—Prednisolone—ulcerative colitis	0.000146	0.0257	CbGdCrCtD
Lapatinib—Nervous system disorder—Prednisone—ulcerative colitis	0.000145	0.00123	CcSEcCtD
Lapatinib—Skin disorder—Prednisone—ulcerative colitis	0.000144	0.00122	CcSEcCtD
Lapatinib—Asthenia—Hydrocortisone—ulcerative colitis	0.000143	0.00121	CcSEcCtD
Lapatinib—Anorexia—Prednisone—ulcerative colitis	0.000141	0.0012	CcSEcCtD
Lapatinib—Pruritus—Hydrocortisone—ulcerative colitis	0.000141	0.0012	CcSEcCtD
Lapatinib—Gastrointestinal pain—Betamethasone—ulcerative colitis	0.000139	0.00118	CcSEcCtD
Lapatinib—Gastrointestinal pain—Dexamethasone—ulcerative colitis	0.000139	0.00118	CcSEcCtD
Lapatinib—Hypersensitivity—Triamcinolone—ulcerative colitis	0.000138	0.00117	CcSEcCtD
Lapatinib—Hypersensitivity—Methylprednisolone—ulcerative colitis	0.000138	0.00117	CcSEcCtD
Lapatinib—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000136	0.00116	CcSEcCtD
Lapatinib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000135	0.00115	CcSEcCtD
Lapatinib—Asthenia—Triamcinolone—ulcerative colitis	0.000135	0.00114	CcSEcCtD
Lapatinib—Abdominal pain—Betamethasone—ulcerative colitis	0.000135	0.00114	CcSEcCtD
Lapatinib—Abdominal pain—Dexamethasone—ulcerative colitis	0.000135	0.00114	CcSEcCtD
Lapatinib—Asthenia—Methylprednisolone—ulcerative colitis	0.000134	0.00114	CcSEcCtD
Lapatinib—Insomnia—Prednisone—ulcerative colitis	0.000134	0.00114	CcSEcCtD
Lapatinib—Pruritus—Triamcinolone—ulcerative colitis	0.000133	0.00113	CcSEcCtD
Lapatinib—Pruritus—Methylprednisolone—ulcerative colitis	0.000132	0.00112	CcSEcCtD
Lapatinib—Dyspepsia—Prednisone—ulcerative colitis	0.00013	0.00111	CcSEcCtD
Lapatinib—Decreased appetite—Prednisone—ulcerative colitis	0.000129	0.00109	CcSEcCtD
Lapatinib—Rash—Prednisolone—ulcerative colitis	0.000129	0.00109	CcSEcCtD
Lapatinib—Dermatitis—Prednisolone—ulcerative colitis	0.000128	0.00109	CcSEcCtD
Lapatinib—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000128	0.00109	CcSEcCtD
Lapatinib—Fatigue—Prednisone—ulcerative colitis	0.000128	0.00108	CcSEcCtD
Lapatinib—Headache—Prednisolone—ulcerative colitis	0.000128	0.00108	CcSEcCtD
Lapatinib—Constipation—Prednisone—ulcerative colitis	0.000127	0.00108	CcSEcCtD
Lapatinib—Vomiting—Hydrocortisone—ulcerative colitis	0.000127	0.00108	CcSEcCtD
Lapatinib—Rash—Hydrocortisone—ulcerative colitis	0.000126	0.00107	CcSEcCtD
Lapatinib—Dermatitis—Hydrocortisone—ulcerative colitis	0.000125	0.00107	CcSEcCtD
Lapatinib—Headache—Hydrocortisone—ulcerative colitis	0.000125	0.00106	CcSEcCtD
Lapatinib—PIK3C2B—Levonorgestrel—Hydrocortisone—ulcerative colitis	0.000123	0.0217	CbGdCrCtD
Lapatinib—Asthenia—Betamethasone—ulcerative colitis	0.000122	0.00104	CcSEcCtD
Lapatinib—Asthenia—Dexamethasone—ulcerative colitis	0.000122	0.00104	CcSEcCtD
Lapatinib—Gastrointestinal pain—Prednisone—ulcerative colitis	0.000121	0.00103	CcSEcCtD
Lapatinib—Nausea—Prednisolone—ulcerative colitis	0.000121	0.00103	CcSEcCtD
Lapatinib—Pruritus—Betamethasone—ulcerative colitis	0.00012	0.00102	CcSEcCtD
Lapatinib—Pruritus—Dexamethasone—ulcerative colitis	0.00012	0.00102	CcSEcCtD
Lapatinib—Vomiting—Triamcinolone—ulcerative colitis	0.000119	0.00101	CcSEcCtD
Lapatinib—Vomiting—Methylprednisolone—ulcerative colitis	0.000119	0.00101	CcSEcCtD
Lapatinib—Nausea—Hydrocortisone—ulcerative colitis	0.000118	0.001	CcSEcCtD
Lapatinib—Rash—Triamcinolone—ulcerative colitis	0.000118	0.001	CcSEcCtD
Lapatinib—Dermatitis—Triamcinolone—ulcerative colitis	0.000118	0.001	CcSEcCtD
Lapatinib—Rash—Methylprednisolone—ulcerative colitis	0.000118	0.001	CcSEcCtD
Lapatinib—Dermatitis—Methylprednisolone—ulcerative colitis	0.000118	0.001	CcSEcCtD
Lapatinib—Headache—Triamcinolone—ulcerative colitis	0.000117	0.000998	CcSEcCtD
Lapatinib—Headache—Methylprednisolone—ulcerative colitis	0.000117	0.000995	CcSEcCtD
Lapatinib—Abdominal pain—Prednisone—ulcerative colitis	0.000117	0.000995	CcSEcCtD
Lapatinib—Diarrhoea—Dexamethasone—ulcerative colitis	0.000116	0.000989	CcSEcCtD
Lapatinib—Diarrhoea—Betamethasone—ulcerative colitis	0.000116	0.000989	CcSEcCtD
Lapatinib—Nausea—Triamcinolone—ulcerative colitis	0.000111	0.000946	CcSEcCtD
Lapatinib—Nausea—Methylprednisolone—ulcerative colitis	0.000111	0.000944	CcSEcCtD
Lapatinib—Hypersensitivity—Prednisone—ulcerative colitis	0.000109	0.000927	CcSEcCtD
Lapatinib—Vomiting—Betamethasone—ulcerative colitis	0.000108	0.000919	CcSEcCtD
Lapatinib—Vomiting—Dexamethasone—ulcerative colitis	0.000108	0.000919	CcSEcCtD
Lapatinib—Rash—Betamethasone—ulcerative colitis	0.000107	0.000911	CcSEcCtD
Lapatinib—Rash—Dexamethasone—ulcerative colitis	0.000107	0.000911	CcSEcCtD
Lapatinib—Dermatitis—Dexamethasone—ulcerative colitis	0.000107	0.00091	CcSEcCtD
Lapatinib—Dermatitis—Betamethasone—ulcerative colitis	0.000107	0.00091	CcSEcCtD
Lapatinib—Headache—Betamethasone—ulcerative colitis	0.000107	0.000905	CcSEcCtD
Lapatinib—Headache—Dexamethasone—ulcerative colitis	0.000107	0.000905	CcSEcCtD
Lapatinib—Asthenia—Prednisone—ulcerative colitis	0.000106	0.000903	CcSEcCtD
Lapatinib—Pruritus—Prednisone—ulcerative colitis	0.000105	0.00089	CcSEcCtD
Lapatinib—ERBB2—Levonorgestrel—Hydrocortisone—ulcerative colitis	0.000102	0.0178	CbGdCrCtD
Lapatinib—Diarrhoea—Prednisone—ulcerative colitis	0.000101	0.000861	CcSEcCtD
Lapatinib—Nausea—Dexamethasone—ulcerative colitis	0.000101	0.000858	CcSEcCtD
Lapatinib—Nausea—Betamethasone—ulcerative colitis	0.000101	0.000858	CcSEcCtD
Lapatinib—Vomiting—Prednisone—ulcerative colitis	9.42e-05	0.0008	CcSEcCtD
Lapatinib—Rash—Prednisone—ulcerative colitis	9.34e-05	0.000793	CcSEcCtD
Lapatinib—Dermatitis—Prednisone—ulcerative colitis	9.34e-05	0.000793	CcSEcCtD
Lapatinib—Headache—Prednisone—ulcerative colitis	9.28e-05	0.000788	CcSEcCtD
Lapatinib—Nausea—Prednisone—ulcerative colitis	8.8e-05	0.000747	CcSEcCtD
Lapatinib—ERBB4—Signaling Pathways—RIPK2—ulcerative colitis	3.53e-05	0.000272	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CRP—ulcerative colitis	3.51e-05	0.000271	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—NFKB1—ulcerative colitis	3.51e-05	0.000271	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IRF8—ulcerative colitis	3.48e-05	0.000269	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CCR6—ulcerative colitis	3.48e-05	0.000269	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	3.48e-05	0.000269	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL6—ulcerative colitis	3.47e-05	0.000268	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—ulcerative colitis	3.45e-05	0.000267	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—NFKB1—ulcerative colitis	3.42e-05	0.000264	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—TLR4—ulcerative colitis	3.42e-05	0.000264	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—HLA-DRB1—ulcerative colitis	3.42e-05	0.000264	CbGpPWpGaD
Lapatinib—EGFR—Disease—SLC11A1—ulcerative colitis	3.39e-05	0.000262	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—ADCY5—ulcerative colitis	3.38e-05	0.000261	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—NFKB1—ulcerative colitis	3.37e-05	0.00026	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—TLR4—ulcerative colitis	3.37e-05	0.00026	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—HLA-DRB1—ulcerative colitis	3.36e-05	0.00026	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TGFB1—ulcerative colitis	3.36e-05	0.00026	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—PTGER4—ulcerative colitis	3.35e-05	0.000259	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—JAK2—ulcerative colitis	3.35e-05	0.000259	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—IL6—ulcerative colitis	3.34e-05	0.000258	CbGpPWpGaD
Lapatinib—EGFR—Immune System—FCGR2A—ulcerative colitis	3.32e-05	0.000256	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—TNF—ulcerative colitis	3.32e-05	0.000256	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—ICAM1—ulcerative colitis	3.28e-05	0.000253	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.25e-05	0.000251	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CHP1—ulcerative colitis	3.24e-05	0.00025	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—ICAM1—ulcerative colitis	3.23e-05	0.000249	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—DLD—ulcerative colitis	3.23e-05	0.000249	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—IL6—ulcerative colitis	3.19e-05	0.000247	CbGpPWpGaD
Lapatinib—EGFR—Immune System—PTPN2—ulcerative colitis	3.18e-05	0.000246	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—ulcerative colitis	3.17e-05	0.000245	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—IL6—ulcerative colitis	3.14e-05	0.000243	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—TNF—ulcerative colitis	3.14e-05	0.000243	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ADRB2—ulcerative colitis	3.11e-05	0.00024	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—GHRL—ulcerative colitis	3.07e-05	0.000237	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	3.06e-05	0.000236	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ADRB2—ulcerative colitis	3.06e-05	0.000236	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCR1—ulcerative colitis	3.06e-05	0.000236	CbGpPWpGaD
Lapatinib—EGFR—Disease—MAML2—ulcerative colitis	3.05e-05	0.000235	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	3.04e-05	0.000234	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—NFKB1—ulcerative colitis	3.02e-05	0.000233	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—IL6—ulcerative colitis	3e-05	0.000232	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—IL6—ulcerative colitis	2.99e-05	0.000231	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CALM3—ulcerative colitis	2.97e-05	0.00023	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—IL6—ulcerative colitis	2.97e-05	0.00023	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CRP—ulcerative colitis	2.96e-05	0.000229	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—IL6—ulcerative colitis	2.96e-05	0.000229	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CDH1—ulcerative colitis	2.9e-05	0.000224	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CHP1—ulcerative colitis	2.89e-05	0.000223	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.86e-05	0.000221	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—PPARG—ulcerative colitis	2.86e-05	0.000221	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CDH1—ulcerative colitis	2.86e-05	0.000221	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—TLR4—ulcerative colitis	2.84e-05	0.000219	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CHP1—ulcerative colitis	2.82e-05	0.000218	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—DLD—ulcerative colitis	2.8e-05	0.000216	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—ulcerative colitis	2.78e-05	0.000215	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—IL6—ulcerative colitis	2.78e-05	0.000215	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—IL6—ulcerative colitis	2.78e-05	0.000215	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—MMP9—ulcerative colitis	2.76e-05	0.000213	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—IL6—ulcerative colitis	2.76e-05	0.000213	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—IL6—ulcerative colitis	2.73e-05	0.000211	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—HLA-DRB1—ulcerative colitis	2.72e-05	0.00021	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—IL6—ulcerative colitis	2.72e-05	0.00021	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CALM3—ulcerative colitis	2.72e-05	0.00021	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—STAT3—ulcerative colitis	2.71e-05	0.00021	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.71e-05	0.000209	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCL20—ulcerative colitis	2.69e-05	0.000207	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RIPK2—ulcerative colitis	2.68e-05	0.000207	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CTLA4—ulcerative colitis	2.64e-05	0.000204	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—ADCY5—ulcerative colitis	2.64e-05	0.000204	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—ICAM1—ulcerative colitis	2.61e-05	0.000202	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—ADCY5—ulcerative colitis	2.6e-05	0.000201	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—JAK2—ulcerative colitis	2.54e-05	0.000196	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—ADRB2—ulcerative colitis	2.54e-05	0.000196	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—IL6—ulcerative colitis	2.53e-05	0.000196	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GNA12—ulcerative colitis	2.52e-05	0.000195	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD79A—ulcerative colitis	2.52e-05	0.000194	CbGpPWpGaD
Lapatinib—EGFR—Disease—CALM3—ulcerative colitis	2.51e-05	0.000194	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—JAK2—ulcerative colitis	2.5e-05	0.000193	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—DLD—ulcerative colitis	2.5e-05	0.000193	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IFNG—ulcerative colitis	2.49e-05	0.000193	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—ulcerative colitis	2.47e-05	0.00019	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—RELA—ulcerative colitis	2.46e-05	0.00019	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IFNG—ulcerative colitis	2.46e-05	0.00019	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—DLD—ulcerative colitis	2.44e-05	0.000188	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	2.43e-05	0.000187	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NOD2—ulcerative colitis	2.43e-05	0.000187	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—RELA—ulcerative colitis	2.42e-05	0.000187	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD14—ulcerative colitis	2.41e-05	0.000186	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD4—ulcerative colitis	2.41e-05	0.000186	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCR2—ulcerative colitis	2.39e-05	0.000185	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—JAK2—ulcerative colitis	2.39e-05	0.000185	CbGpPWpGaD
Lapatinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—ulcerative colitis	2.38e-05	0.000184	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD4—ulcerative colitis	2.37e-05	0.000183	CbGpPWpGaD
Lapatinib—ERBB2—Disease—JAK2—ulcerative colitis	2.35e-05	0.000181	CbGpPWpGaD
Lapatinib—EGFR—Immune System—VCAM1—ulcerative colitis	2.33e-05	0.00018	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DQA1—ulcerative colitis	2.32e-05	0.000179	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—RELA—ulcerative colitis	2.31e-05	0.000179	CbGpPWpGaD
Lapatinib—ERBB4—Disease—JAK2—ulcerative colitis	2.31e-05	0.000179	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CDH1—ulcerative colitis	2.31e-05	0.000179	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CCR6—ulcerative colitis	2.25e-05	0.000174	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—IL6—ulcerative colitis	2.24e-05	0.000173	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL1B—ulcerative colitis	2.23e-05	0.000172	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD4—ulcerative colitis	2.22e-05	0.000172	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2—ulcerative colitis	2.22e-05	0.000171	CbGpPWpGaD
Lapatinib—ERBB2—Disease—PTGS2—ulcerative colitis	2.21e-05	0.000171	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—IL6—ulcerative colitis	2.2e-05	0.00017	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL1B—ulcerative colitis	2.19e-05	0.000169	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD4—ulcerative colitis	2.19e-05	0.000169	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2—ulcerative colitis	2.18e-05	0.000169	CbGpPWpGaD
Lapatinib—ERBB4—Disease—PTGS2—ulcerative colitis	2.18e-05	0.000168	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—ADCY5—ulcerative colitis	2.16e-05	0.000167	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAML2—ulcerative colitis	2.13e-05	0.000165	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—JAK2—ulcerative colitis	2.11e-05	0.000163	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.11e-05	0.000163	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—NFKB1—ulcerative colitis	2.08e-05	0.00016	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—NFKB1—ulcerative colitis	2.04e-05	0.000158	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—RELA—ulcerative colitis	2.04e-05	0.000158	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD4—ulcerative colitis	2e-05	0.000155	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—PTGER4—ulcerative colitis	1.98e-05	0.000153	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—MMP9—ulcerative colitis	1.97e-05	0.000152	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ADCY5—ulcerative colitis	1.97e-05	0.000152	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—RELA—ulcerative colitis	1.96e-05	0.000152	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—NFKB1—ulcerative colitis	1.95e-05	0.000151	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD4—ulcerative colitis	1.92e-05	0.000148	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—IL6—ulcerative colitis	1.9e-05	0.000146	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—STAT3—ulcerative colitis	1.87e-05	0.000144	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—STAT3—ulcerative colitis	1.84e-05	0.000142	CbGpPWpGaD
Lapatinib—EGFR—Disease—ADCY5—ulcerative colitis	1.82e-05	0.000141	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—GHRL—ulcerative colitis	1.81e-05	0.00014	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CALM3—ulcerative colitis	1.76e-05	0.000136	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.75e-05	0.000136	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—STAT3—ulcerative colitis	1.75e-05	0.000135	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.74e-05	0.000134	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RIPK2—ulcerative colitis	1.73e-05	0.000134	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CRP—ulcerative colitis	1.72e-05	0.000133	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—NFKB1—ulcerative colitis	1.72e-05	0.000133	CbGpPWpGaD
Lapatinib—ERBB2—Disease—STAT3—ulcerative colitis	1.72e-05	0.000133	CbGpPWpGaD
Lapatinib—EGFR—Axon guidance—IL6—ulcerative colitis	1.72e-05	0.000133	CbGpPWpGaD
Lapatinib—ERBB4—Disease—STAT3—ulcerative colitis	1.7e-05	0.000131	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—NFKB1—ulcerative colitis	1.65e-05	0.000128	CbGpPWpGaD
Lapatinib—EGFR—Immune System—TLR4—ulcerative colitis	1.65e-05	0.000128	CbGpPWpGaD
Lapatinib—EGFR—Immune System—HLA-DRB1—ulcerative colitis	1.65e-05	0.000128	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—JAK2—ulcerative colitis	1.64e-05	0.000127	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.64e-05	0.000127	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.64e-05	0.000127	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TGFB1—ulcerative colitis	1.63e-05	0.000126	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—JAK2—ulcerative colitis	1.62e-05	0.000125	CbGpPWpGaD
Lapatinib—ERBB2—Disease—TGFB1—ulcerative colitis	1.6e-05	0.000123	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—RELA—ulcerative colitis	1.59e-05	0.000123	CbGpPWpGaD
Lapatinib—EGFR—Immune System—ICAM1—ulcerative colitis	1.59e-05	0.000122	CbGpPWpGaD
Lapatinib—ERBB4—Disease—TGFB1—ulcerative colitis	1.57e-05	0.000121	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—RELA—ulcerative colitis	1.57e-05	0.000121	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS1—ulcerative colitis	1.56e-05	0.000121	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—TNF—ulcerative colitis	1.52e-05	0.000117	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADRB2—ulcerative colitis	1.5e-05	0.000116	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—DLD—ulcerative colitis	1.5e-05	0.000116	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—CXCL8—ulcerative colitis	1.5e-05	0.000116	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.48e-05	0.000114	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—CXCL8—ulcerative colitis	1.48e-05	0.000114	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.44e-05	0.000112	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2—ulcerative colitis	1.43e-05	0.000111	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2—ulcerative colitis	1.41e-05	0.000109	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—CALM3—ulcerative colitis	1.41e-05	0.000109	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CDH1—ulcerative colitis	1.4e-05	0.000108	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MMP9—ulcerative colitis	1.36e-05	0.000105	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS1—ulcerative colitis	1.35e-05	0.000104	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—JAK2—ulcerative colitis	1.34e-05	0.000104	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—NFKB1—ulcerative colitis	1.34e-05	0.000104	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MMP9—ulcerative colitis	1.34e-05	0.000103	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.33e-05	0.000103	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—NFKB1—ulcerative colitis	1.32e-05	0.000102	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.32e-05	0.000102	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL6—ulcerative colitis	1.3e-05	0.000101	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL6—ulcerative colitis	1.28e-05	9.92e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—ADCY5—ulcerative colitis	1.27e-05	9.84e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—JAK2—ulcerative colitis	1.23e-05	9.49e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—CXCL8—ulcerative colitis	1.23e-05	9.48e-05	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—IL6—ulcerative colitis	1.22e-05	9.46e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—CALM3—ulcerative colitis	1.22e-05	9.4e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS1—ulcerative colitis	1.21e-05	9.32e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—STAT3—ulcerative colitis	1.21e-05	9.32e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IFNG—ulcerative colitis	1.21e-05	9.32e-05	CbGpPWpGaD
Lapatinib—ERBB2—Disease—IL6—ulcerative colitis	1.2e-05	9.29e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—RELA—ulcerative colitis	1.19e-05	9.19e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—STAT3—ulcerative colitis	1.19e-05	9.18e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.19e-05	9.17e-05	CbGpPWpGaD
Lapatinib—ERBB4—Disease—IL6—ulcerative colitis	1.19e-05	9.16e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS1—ulcerative colitis	1.18e-05	9.1e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2—ulcerative colitis	1.17e-05	9.06e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD4—ulcerative colitis	1.16e-05	9e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.16e-05	8.99e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—JAK2—ulcerative colitis	1.13e-05	8.76e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TGFB1—ulcerative colitis	1.12e-05	8.64e-05	CbGpPWpGaD
Lapatinib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	1.1e-05	8.51e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TGFB1—ulcerative colitis	1.1e-05	8.51e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ABCB1—ulcerative colitis	1.09e-05	8.44e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—CALM3—ulcerative colitis	1.09e-05	8.39e-05	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—IL6—ulcerative colitis	1.08e-05	8.36e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL1B—ulcerative colitis	1.08e-05	8.31e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD4—ulcerative colitis	1.08e-05	8.31e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2—ulcerative colitis	1.07e-05	8.28e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—PTGS2—ulcerative colitis	1.07e-05	8.25e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—CALM3—ulcerative colitis	1.06e-05	8.19e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	1.04e-05	8.02e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ADCY5—ulcerative colitis	1.02e-05	7.87e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—NFKB1—ulcerative colitis	1e-05	7.75e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ABCB1—ulcerative colitis	9.46e-06	7.31e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—ulcerative colitis	9.2e-06	7.11e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—ulcerative colitis	9.07e-06	7e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—STAT3—ulcerative colitis	9.02e-06	6.97e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ADCY5—ulcerative colitis	8.83e-06	6.82e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ABCB1—ulcerative colitis	8.45e-06	6.53e-05	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL6—ulcerative colitis	8.42e-06	6.51e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—STAT3—ulcerative colitis	8.33e-06	6.43e-05	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL6—ulcerative colitis	8.3e-06	6.41e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—JAK2—ulcerative colitis	7.94e-06	6.14e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ADCY5—ulcerative colitis	7.88e-06	6.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—TGFB1—ulcerative colitis	7.72e-06	5.96e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—RELA—ulcerative colitis	7.69e-06	5.94e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ADCY5—ulcerative colitis	7.69e-06	5.94e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PPARG—ulcerative colitis	7.6e-06	5.87e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS1—ulcerative colitis	7.26e-06	5.6e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—CXCL8—ulcerative colitis	7.25e-06	5.6e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2—ulcerative colitis	6.93e-06	5.35e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL6—ulcerative colitis	6.89e-06	5.33e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—ALB—ulcerative colitis	6.84e-06	5.28e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PPARG—ulcerative colitis	6.58e-06	5.09e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MMP9—ulcerative colitis	6.56e-06	5.07e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—CALM3—ulcerative colitis	6.53e-06	5.05e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—NFKB1—ulcerative colitis	6.49e-06	5.01e-05	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL6—ulcerative colitis	6.3e-06	4.87e-05	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—PTGS2—ulcerative colitis	5.98e-06	4.62e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—ALB—ulcerative colitis	5.92e-06	4.57e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PPARG—ulcerative colitis	5.88e-06	4.54e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—STAT3—ulcerative colitis	5.83e-06	4.5e-05	CbGpPWpGaD
Lapatinib—EGFR—Disease—IL6—ulcerative colitis	5.82e-06	4.49e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PPARG—ulcerative colitis	5.74e-06	4.43e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TGFB1—ulcerative colitis	5.41e-06	4.18e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—ALB—ulcerative colitis	5.28e-06	4.08e-05	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—PTGS2—ulcerative colitis	5.18e-06	4e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—ALB—ulcerative colitis	5.16e-06	3.98e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ABCB1—ulcerative colitis	5.08e-06	3.92e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ADCY5—ulcerative colitis	4.74e-06	3.66e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—PTGS2—ulcerative colitis	4.62e-06	3.57e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—PTGS2—ulcerative colitis	4.51e-06	3.49e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—ulcerative colitis	4.45e-06	3.44e-05	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL6—ulcerative colitis	4.07e-06	3.15e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PPARG—ulcerative colitis	3.53e-06	2.73e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—ALB—ulcerative colitis	3.18e-06	2.46e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.78e-06	2.15e-05	CbGpPWpGaD
